Home/Filings/4/0000950170-24-122295
4//SEC Filing

Sullivan Lynne Marie 4

Accession 0000950170-24-122295

CIK 0001463361other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 4:10 PM ET

Size

5.1 KB

Accession

0000950170-24-122295

Insider Transaction Report

Form 4
Period: 2024-11-04
Sullivan Lynne Marie
CFO & Head of Corp. Dev.
Transactions
  • Sale

    Common Stock, $0.0001 par value

    2024-11-04$1.29/sh136$17555,925 total
Footnotes (2)
  • [F1]Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]Includes Restricted Stock Units which vest over time measured from the grant date.

Documents

1 file

Issuer

Unity Biotechnology, Inc.

CIK 0001463361

Entity typeother

Related Parties

1
  • filerCIK 0001727640

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:10 PM ET
Size
5.1 KB